Status:

COMPLETED

A Phase III Study of Pancreatic Cancer

Lead Sponsor:

National Health Research Institutes, Taiwan

Collaborating Sponsors:

National Taiwan University Hospital

Chang Gung Memorial Hospital

Conditions:

Pancreatic Cancer

Eligibility:

All Genders

20-75 years

Brief Summary

Study Design: Adjuvant gemcitabine therapy has been shown to improve recurrence-free survival in pancreatic cancer underwent curative intent resection. This study is to evaluate whether combining conc...

Detailed Description

Treatment plan and Randomization scheme:: Patients will be randomized after stratification according to pathology report on section margin, tumor size, lymph node metastasis: Patients who are random...

Eligibility Criteria

Inclusion

  • A.Eligibility Criteria
  • Patients with pancreatic cancer after curative intent resection.
  • The histology of resected tumor has to be adenocarcinoma.
  • Age 20-75 years.
  • ECOG performance scale 0-1.
  • Patients must have normal organ and marrow function as defined below.
  • The effects of study agents on the developing human fetus at the recommended therapeutic dose are unknown.
  • to sign a written informed consent.
  • Registered within 6 weeks after surgery.
  • Preoperative abdominal CT or MRI with contrast enhancement.
  • B.Exclusion Criteria
  • Patients with gross residual, macroscopic positive resection margin or distant metastases.
  • Patients may not be receiving any other investigational agents.
  • Patients who have had prior chemotherapy or radiotherapy are not eligible.
  • History of allergic reactions.
  • Patients who had non-curable second primary malignancy.
  • Uncontrolled intercurrent illness including.
  • Pregnant women.
  • receiving immuno-suppressive therapy、anti-coagulants.

Exclusion

    Key Trial Info

    Start Date :

    February 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2016

    Estimated Enrollment :

    147 Patients enrolled

    Trial Details

    Trial ID

    NCT00994721

    Start Date

    February 1 2009

    End Date

    January 1 2016

    Last Update

    May 4 2016

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Chang-Gung Memorial Hospital

    Taipei, Taiwan

    2

    Mackay Memorial Hospital

    Taipei, Taiwan

    3

    National Taiwan University Hospital

    Taipei, Taiwan